Shanghai City, China Clinical Trials

A listing of Shanghai City, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 100 clinical trials
Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer

The purpose of this study is to compare the rate of disease free survival (DFS) and distant disease free survival (DDFS) at 5 years in postmenopausal women with hormone receptor and lymph node positive breast cancer randomized between anastrozole/letrozole 5 years and anastrozole/letrozole 2-3 years switching to exemestane 3-2 years.

gonadotropin releasing hormone
cancer surgery
ductal carcinoma in situ
  • 07 Nov, 2020
  • 1 location
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

To compare the efficacy of Medroxyprogesterone Acetate with dydrogesterone in patients having endometrial hyperplasia (EH) without atypia.

Obstetrics and Gynecology Hospital, Fudan University
 (1.8 away) Contact site
  • 25 Jan, 2021
  • 1 location
Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

The study is a prospective, single-arm, open label, exploratory phase 2 clinical trial, which aims to study the therapeutic effect of letrozole combined with anlotinib hydrochloride in platinum-resistant recurrent ovarian cancer.

Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine
 (3.6 away) Contact site
  • 28 Jan, 2021
  • 1 location
A Study of SHR-1210 SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

This is a randomized, open-label, 3-arm Phase 2 study to evaluate the efficacy and safety of SHR-1210 alone or with SHR-1020 versus physician's choice chemotherapy in recurrent or metastatic cervical cancer patients. All enrolled patients will be randomly divided into 3 groups and receive treatment until disease progression, intolerable toxicityany …

Fudan University Shanghai Cancer Center
 (2.3 away) Contact site
  • 30 Apr, 2021
  • 1 location
Study on TIL for the Treatment of r/r Gynecologic Tumors

This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with malignant refractory/relapsed gynecologic tumors. Autologous TILs are expanded from tumor resections or biopsies and infused i.v. into the patient after NMA lymphodepletion treatment with fludarabine and cyclophosphamide.

  • 28 Feb, 2021
  • 1 location
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

In the study, subjects will scheduled to undergo four 21-days cycles of chemotherapy treatment. Three group were treated with MW05 300 g/kg or MW05 500 g/kg or PEG-rhG-CSF 100 g/kg on the 3th day of each cycle randomized 1:1:1 . The dose of the experimental drug MW05 in phase III …

Fudan University affiliated cancer hospital
 (0.0 away) Contact site
  • 26 Jan, 2021
  • 1 location
RCT for SSLF vs. ISFF With Conventional Surgical Instruments in Chinese Apical Prolapse Female Patients

This trial is designed to investigate the efficacy and safety of two native tissue repair procedure with conventional surgical instruments in Chinese apical prolapse female patients (POP-Q II-IV) and compare the outcome in prolapse women randomized to Sacrospinous ligament fixation (SSLF) and Ischial spinous fascia fixation (ISFF).

Shanghai First Maternity and Infant Hospital
 (1.7 away) Contact site
  • 23 Jan, 2021
  • +4 other locations
Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western Medicine

Our study used a randomized controlled trial to validate the clinical efficacy of a combination of traditional Chinese and Western medicine in the treatment of children with rapid progressive central precocious puberty.

Children's Hospital of Fudan University
 (7.0 away) Contact site
  • 24 Jan, 2021
  • 1 location
A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)

The study is to evaluate the efficacy and safety of two doses of xiangjurupining capsule in Hyperplastic disease of breast patients .

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
 (0.0 away) Contact site
  • 11 Apr, 2021
  • +7 other locations
A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.

To evaluate the efficacy,safety and immunogenicity of TQ-B211 plus docetaxel versus Herceptin plus docetaxel in Patients with HER2-positive metastatic breast cancer.Trastuzumab plus docetaxel was chosen as the comparator in the control group,as it represents a common first-line treatment option used in HER2+ MBC population in China.

Fudan University Shanghai Cancer Center
 (6.8 away) Contact site
  • 25 Jan, 2021
  • +1 other locations